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Summary
Background The Philippines has the highest cumulative COVID-19 cases and deaths in the Western-Pacific. To
explore the broader health impacts of the pandemic, we assessed the magnitude and duration of changes in hospital
admissions for 12 high-burden diseases and the utilization of five common procedures by lockdown stringency, hos-
pital level, and equity in patient access.
Methods Our analysis used Philippine social health insurance data filed by 1,295 hospitals in 2019 and 2020. We
calculated three descriptive statistics of percent change comparing 2020 to the same periods in 2019: (1) year-on-
year, (2) same-month-prior-year, and (3) lockdown periods.
Findings Disease admissions declined (-54%) while procedures increased (13%) in 2020 versus 2019. The increase
in procedures was caused by hemodialysis surpassing its 2019 utilization levels in 2020 by 25%, overshadowing
declines for C-section (-5%) and vaginal delivery (-18%). Comparing months in 2020 to the same months in 2019,
the declines in admissions and procedures occurred at pandemic onset (March-April 2020), with some recovery
starting May, but were generally not reversed by the end of 2020. Non-urgent procedures and respiratory diseases
faced the largest declines in April 2020 versus April 2019 (range: -60% to -70%), followed by diseases requiring reg-
ular follow-up (-50% to -56%), then urgent conditions (-4% to -40%). During the strictest (April-May 2020) and
relaxed (May-December 2020) lockdown periods compared to the same periods in 2019, the declines among the
poorest (-21%, -39%) were three-times greater than in direct contributors (-7%, -12%) and two-times more in the
south (-16%, -32%) than the richer north (-8%, -10%). Year-on-year admission declines across the 12 diseases and
procedures (except for hemodialysis) was highest for level three hospitals. Compared to public hospitals, private hos-
pitals had smaller year-on-year declines for procedures, because of increases in utilization in lower level private
hospitals.
Interpretation COVID-19’s prolonged impact on the utilization of hospital services in the Philippines suggests a
looming public health crisis in countries with frail health systems. Through the periodic waves of COVID-19 and
lockdowns, policymakers must employ a whole-of-health strategy considering all conditions, service delivery net-
works, and access for the most vulnerable.
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Copyright  2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
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Introduction
Global numbers of coronavirus disease-19 (COVID-19)
cases and deaths fail to capture broader pandemic
health impacts on non-COVID-19 healthcare utilization.
This is particularly true in many low-and-middle
income countries (LMICs) where health information
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systems are weak and spillover effects of the pandemic
may be difficult to measure.1
The Philippines is an LMIC where COVID-19
remains a continuing public health crisis with over
2.4 million confirmed cases and 37 thousand deaths as
of 22 September 2021 - the highest in the Western-
Pacific region.2 Evidence shows that the COVID-19 pan-
demic, which precipitated state-imposed lockdowns and
negative health system changes in many countries, have
led to declining use of essential healthcare and deterio-
rating population health-status and well-being.3−5 Better
understanding of the indirect consequences of the pan-
demic in LMICs would assist global and local decision-
makers in implementing a more holistic and calibrated
response, particularly while LMICs continue to have
limited access to effective vaccines and where their
capacity for pandemic control has varied based on pub-
lic trust, government resources, and health system
weaknesses.6−8
To this end, we assessed the magnitude and duration
of changes in hospital utilization in the Philippines for
12 diseases, which account for half the total disease bur-
den in the country,9 and the five most-commonly uti-
lized hospital procedures. In concern for a systems-
Research in context
Evidence before this study
Literature shows that the COVID-19 pandemic, which
precipitated state-mandated lockdowns and various
negative health system changes, decreased the utiliza-
tion of essential non-COVID-19 healthcare, especially for
vulnerable groups. A multi-country systematic review
across 20 high income countries (HICs) reported a
median 37% reduction in healthcare utilization during
the pandemic. Our results on the magnitude of drops in
hospital utilization is comparable for non-urgent and
respiratory diseases in South Korea, dengue in China,
diabetes in the USA, acute coronary syndromes in Eng-
land, and stroke globally.
Added value of this study
Our study contributes to literature in three ways. First,
we provide estimates for diseases and procedures not
yet well-studied. Tuberculosis inpatient admissions
declined by -62% at the height of the lockdown in April
2020 compared to April 2019. This trend continued until
December 2020, facing -40% to -60% declines relative
to the same periods in 2019. Chemotherapy utilization
in the Philippines faced a modest drop of -30% in April
2020 versus April 2019, but steadily recovered in the
succeeding months of 2020 to December 2019 levels.
Remarkably, hemodialysis utilization for all months in
2020 were similar to their respective months in 2019,
with growth starting in August 2020 (13%) to December
2020 (150%). This is attributable to an increase in social
health insurance (SHI) coverage of hemodialysis from
90 to 144 sessions per year for 2020, since policymakers
were concerned about the affordability of this life-sav-
ing procedure during the pandemic.
Second, we provide insight on equity in utilization
by hospital characteristics cross-tabulated with condi-
tions: Year-on-year declines in disease admissions were
largest for Level 3 hospitals across diseases and sectors
(public level 3 median: -49%, private level 3 median:
-52%). Overall, for procedures, government hospitals
suffered a slight decline (-6%) while private hospitals
grew (20%), because declines in level 3 private hospitals
were compensated through increases in utilization of
chemotherapy, C-Section, and vaginal delivery in lower
level private hospitals — a trend absent in public
hospitals.
Lastly, taking our results as a whole, we present an
analysis that can inform a whole-of-system strategy. To
our knowledge, there has been no low-and-middle
income country (LMIC) in Southeast Asia with similar
research on a national scale focusing on the country’s
top diseases and looking across lockdown policies over
time, hospitals, and equity in patient access. For exam-
ple, our results may, in part, reflect the effects of pro-
longed lockdowns without system-wide strategies to
mitigate potential negative effects on non-COVID-19
inpatient utilization. The Philippines is unique in that
varying degrees of lockdown have been the mainstay
response to COVID-19 since March 2020. Contrary to
most literature, which identified a recovery period, med-
ical admissions and procedures captured in the Philip-
pine SHI database showed greater declines in utilization
during the looser lockdown period (-61%) of May-
December 2020 compared to the same period in 2019
than the more stringent period (-36%) of April-May
2020. Of course, apart from lockdowns, our results may
also reflect intentional and unintentional changes in
health system conditions caused by new national poli-
cies and the progression of the pandemic that must be
considered more thoughtfully in a holistic strategy to
control COVID-19. For instance, qualitative reports sug-
gest COVID-19 has overwhelmed the public health sys-
tem as limited government resources are siphoned to
COVID-19 response.
Implications of all the available evidence
The declines in hospital utilization suggest a looming
public health crisis for the Philippines and other LMICs
with frail health systems. Foregone care for infectious
and non-communicable diseases may lead to long-term
increases pre-mature mortality and morbidity with
expensive and impoverishing complications. A whole-
of-health perspective considering all conditions and
procedures, service delivery networks, and access for
the most vulnerable through epidemic waves and lock-
down restrictions is critical. To illustrate, lower-level hos-
pitals may be capacitated and maximized to facilitate
catch-up care. Focus for support and special protections
can also be given to lower-level public hospitals, which
may be the only hospitals accessible in poorer provinces
or rural areas.
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perspective that can inform operational strategy, we also
look at these trends across Philippine lockdown policies




The Philippine health system is decentralized across
three island groups, 17 regions, and local governments
units (LGUs), referring to 81 provinces and the munici-
palities and cities they encompass. The Department of
Health (DOH) is the country’s national health policy
and regulatory body.10 While the DOH manages some
tertiary and specialty hospitals, LGUs and the private
sector are the main providers of healthcare. The Philip-
pine Health Insurance Corporation (PhilHealth) insti-
tutes universal healthcare (UHC) through the national
social health insurance (SHI) program.11 Funded pri-
marily through general taxation, PhilHealth, as the
national purchaser of health services, pays accredited
providers through fixed benefit packages and inpatient
case rates.
Currently, 93% of hospitals are accredited by Phil-
Health. All Filipino citizens are eligible to enroll in Phil-
Health by the UHC Act of 2019, and 87% of 110-million
Filipinos are registered in the national SHI database
and pay premiums.11,12 There are two major member-
ship categories: (1) Direct contributors are from formal-
or informal-labor sectors, whose premiums are self-paid
or covered by employers. (2) Indirect contributors
include senior citizens and indigents, a category for the
poor whose income is insufficient for subsistence. Indi-
rect contributors cannot afford their premiums and rely
on government or private entities to finance them.
Unregistered members or failure to pay premiums does
not prevent enjoyment of PhilHealth benefits. Unregis-
tered patients are enrolled immediately at point-of-care.
Indirect contributors can access PhilHealth benefits
regardless of premium payments while direct contribu-
tors must first retroactively pay missed monthly premi-
ums.
Data
Our analysis was based on PhilHealth inpatient claims
for 12 high-burden diseases and procedural claims for
the five common procedures filed by 1,295 accredited
hospitals from 2019 to 2020. The diseases were: (1)
acute gastroenteritis (AGE), (2) asthma, (3) chronic kid-
ney disease (CKD), (4) chronic obstructive pulmonary
disease (COPD), (5) cancer, (6) dengue, (7) diabetes, (8)
hypertension, (9) ischemic heart disease (IHD), (10)
pneumonia, (11) stroke, and (12) tuberculosis. The pro-
cedures were: (1) cataract surgery, (2) chemotherapy, (3)
cesarean section (C-section), (4) hemodialysis, (5) vagi-
nal delivery. PhilHealth has limited outpatient- and
primary care benefits; thus our data represent only dis-
ease admissions and procedures done in hospitals.
Except for cancer, chemotherapy, C-section, and acute
or severe events for the listed diseases and procedures,
prevention and follow-up care may be done at the pri-
mary care level or an out-patient basis — both of which
were not captured by our data. See supplementary Table
1 for specific conditions under each disease and the list
of disease ICD-10 codes and procedure Relative Value
Scale (RVS) codes.
Data were extracted by PhilHealth on 21 April 2021
and claims that were “returned to hospitals” for incom-
plete documentation and “denied” due to non-compli-
ance or non-compensable reasons were excluded (see
Supplementary Table 2). Returned and denied claims
can be refiled or contested, so their exclusion avoids the
possibility of double-counting. The final sample
includes 4,488,370 claims from 2019 and 3,663,292
claims from 2020. These claims may be “paid”,
“approved for payment”, or “in-process.” Because Phil-
Health policy delineates case rates for multiple condi-
tions, only the ICD-10 or RVS code in the primary
position was used.13 Thus, a claim may reasonably be
assumed to represent one discrete event of service utili-
zation.
PhilHealth data included admission year and month,
hospital characteristics (i.e., level, ownership, province
of location), and patient membership type. Hospitals
were categorized by capacity: Level 1 hospitals provide
emergency and ancillary care; Level 2 hospitals, in addi-
tion, are departmentalized and have intensive care units
and clinical laboratories; Level 3 hospitals are consid-
ered end-referral hospitals.10
To supplement our analyses, we used province
income-class data from the Philippine Statistics Author-
ity to compare the utilization among hospitals in poorer
and richer provinces.14 Income-class is based on average
annual provincial income from local taxes and revenues
over the past four years. First class provinces maintain
an average annual income of at least PHP 400 million
(USD 8 million); second class, PHP 320 million (USD
6.4 million); third class, PHP 240 million (USD 4.8
million); fourth class, PHP 160 million (USD 3.2 mil-
lion); and fifth class, PHP 80 million (USD 1.6
million).15
Finally, we juxtaposed the stringency of lockdowns
in 2020 to PhilHealth claims using admission or proce-
dure month. We focused on three distinct periods: “Pre-
lockdown” (January-February 2020), “Enhanced Com-
munity Quarantine (ECQ)” [March-April 2020], and
“Modified or General Community Quarantine (M/
GCQ)” [May-December 2020]. Lockdowns enforced by
the Philippine government are classified into four with
decreasing strictness: (1) ECQ - entire population except
essential industries under stay-at-home orders, public
transportation and mass gatherings prohibited; (2)
MECQ - limited number of businesses open,
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restaurants for-delivery, and individual outdoor excise
permitted; (3) GCQ - government offices may operate at
full capacity, 25%-50% venue capacity for public gather-
ings, recreational facilities, and restaurants; and (4) M/
GCQ - public gatherings at 50%-75% venue capacity,
and restaurants and gyms fully operational.16 From
mid-March 2020, when lockdowns were initially imple-
mented, until the end of April, the country was under
ECQ. In May, nearly all provinces had transitioned to
GCQ, and by June, most of the country remained under
M/GCQ until December 2020.17 Stricter lockdowns
were sometimes employed in select provinces or smaller
administrative units for short periods of high local
transmission.
Statistical analysis
We retrospectively analyzed PhilHealth claims to derive
total monthly medical admissions and procedure utili-
zation, disaggregated by hospital characteristics, Phil-
Health membership type, and disease or procedure. We
calculated three descriptive statistics of percent change
comparing 2020 to the same periods in 2019: (1) year-
on-year, (2) same-month-prior-year, and (3) lockdown
periods. STATA v17.0 was used for all data processing
and analyses.
To account for the change over time between 2019
and 2020 had the pandemic not occurred, we normal-
ized the monthly totals in 2020 using the method of
Birkmeyer et al.18 Furthermore, since disease incidence
and health care utilization were more prevalent during
certain periods in the year,19 we treated corresponding
time periods in 2019 as controls. Our steps were as fol-
lows: We first created a baseline adjustment factor by
calculating the ratio of average claims in January and
February 2019 and the average claims for the same
months in 2020, as these together represent the pre-
pandemic period (Equation 1). Next, to calculate an
adjusted same-month-prior-year ratio, we multiplied the
baseline adjustment factor with the ratio of 2020 and
2019 admissions or procedure totals for each month.
Adjusted month-on-month percent change is then given
by 1 minus the adjusted same-month-prior-year ratio,
multiplied by 100. Finally, adjusted monthly totals for
2020 were calculated by multiplying the adjusted ratio
with the 2019 monthly claims. These steps were
repeated within all strata of disaggregation.
Equation 1 : Seasonality Adjusted samemonth prior
 year % Change
¼ 1 Baseline Adjustment Factor  samemonth prior year Ratioð Þ½ 
¼ 1 Average claims in January and February 2019
Average claims in January and February 2020
 Claims for month in 2020
Claims for month in 2019
  
For adjusted percent change in lockdown periods,
2019 claims, and 2020 adjusted claims were first aggre-
gated up according to Pre-lockdown (January-February),
ECQ (March-April), and M/GCQ (May-December) peri-
ods then compared. Analyses for year-on-year total
claims for 2019 and 2020 were not seasonally adjusted,
as they already accounted for aggregate seasonal fluctua-
tions in the data.
Ethics approval
Institutional review board approval was deemed
unnecessary as all administrative data used here may
be obtained from government websites (see Data
Availability).
Role of the funding source
The funders of the study did not have any role in study
design, data collection, analysis, interpretation, or writ-
ing of the manuscript.
Results
Majority of PhilHealth-accredited hospitals were Level 1
(65%) and Level 2 (27%) (Table 1). Around 66% were
privately-owned, 86% concentrated in the first-class
provinces of the country, and 45% were located in the
three contiguous regions of the National Capital Region,
Region III, and Region IVa. These regions are consid-
ered the epicenter of economic activity, accounting for
about 60% of the country’s gross domestic product.22
Comparing 2020 to 2019 in aggregate, we observed
a large decline in total admissions for the 12 diseases
(-54%) and a small increase in utilization (13%) for the
five procedures (Table 1). The year-on-year decline in
medical admissions was similar across hospital level,
ownership, location, and province income class. For
procedures, changes in utilization showed some hetero-
geneity: While Level 3 hospitals showed slight decrease
in procedures (-4%), Level 1 (16%), and Level 2 hospitals
(26%) recorded modest growth. Government hospitals
suffered a slight decline in procedures (-6%) while pri-
vate hospitals grew (20%). In terms of hospital location,
Visayas had the highest recorded growth (21%) in proce-
dures; hospitals in fourth- (3%) and fifth-class (-12%)
Articles
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provinces also had lower growth compared to those
from richer provinces.
Figure 1 shows the monthly number of medical
admissions and procedures for 2019 and 2020 overlaid
with Philippines' lockdown periods. A large decline in
medical admissions began in March 2020, coinciding
with the start of national lockdown (Figure 1A). The low-
est number of admissions was recorded in April 2020.
There was a slight recovery in the absolute number of
admissions in May 2020, but this stagnated until
December 2020. Relative to the same months in 2019,
the ECQ period reflected a 36% decline in admissions
while the May-December 2020 M/GCQ period recorded
a 61% decline (Table 2). For procedures, utilization
numbers were stable, with only a very slight decline in
April 2020 and even growth in the last quarter of 2020
(Figure 1A). Comparing the ECQ and M/GCQ periods
in 2020 with the same months in 2019, procedures
reflected a 1% decline and 10% increase, respectively
(Table 2).
Equity-wise, utilization declines for both periods
were largest in Visayas (-17%, -31%) and Mindanao
(-16%, -32%) compared to NCR and Luzon (-8%, -14%).
Among types of PhilHealth members, direct-formal
contributors (-11%, -28%) and the poorest indirect-indi-
gent or sponsored members (-21%, 39%) also suffered
the largest declines in admissions and procedures for
both periods (Table 2).
Figure 2 summarizes the same-month-prior-year
change in healthcare utilization for 2020 relative to
2019 by disease and procedure. Except for hemodialysis,
which recorded large growths in the third quarter of
2020 (Figure 2A), utilization for all diseases and proce-
dures actually declined for every month. The magnitude
of decline, however, varied by disease or procedure
(Figure 2B). Comparing April 2020 with 2019, same-
month-prior-year declines for the non-urgent and respi-
ratory diseases like AGE, asthma, COPD, dengue, pneu-
monia, and cataract surgery were the largest (range:
-60% to -70%). For diabetes, hypertension, IHD, and
tuberculosis or diseases that require regular mainte-
nance consultation or medicines, declines were more
modest (-50% to -56%). The lowest declines were seen
in urgent or non-elective care, including CKD, cancer,
chemotherapy, stroke, c-section, and vaginal delivery
(-4% to -40%).
Table 3 presents year-on-year changes comparing
2020 to 2019 for diseases and procedures by hospital
ownership and level. Disease admissions declined most
in Level 3 hospitals (public median: -49; private median:
-52), followed by Level 2 hospitals (public median: -43;
private median: -42). Compared to public hospitals,
Hospitals (N=1,295) Medical Admissions (12 diseases) Procedures (5 procedures)
n % 2019 2020 % Change 2019 2020 % Change
Total - - 2,102,510 962,770 -54 2,385,860 2,700,522 13
Hospital Level
Level 1 832 64¢2 1,014,939 464,921 -54 439,072 509,565 16
Level 2 344 26¢6 674,156 313,258 -54 1,066,003 1,347,035 26
Level 3 119 9¢2 413,415 184,591 -55 880,785 843,922 -4
Ownership
Government 440 34¢0 960,684 428,882 -55 648,438 608,215 -6
Private 855 66¢0 1,141,826 533,888 -53 1,737,422 2,092,307 20
Location
National Capital Region, Region III,
Region IVa*
564 43¢6 695,786 295,034 -58 1,254,598 1,383,907 10
Luzon 258 19¢9 352,176 211,046 -40 352,176 401,145 14
Visayas 178 13¢7 392,804 214,565 -45 422,449 511,918 21
Mindanao 295 22¢8 590,851 242,125 -59 356,637 403,552 13
Province Income Class
First 1,107 85¢5 1,786,460 806,795 -55 2,160,210 2,442,067 13
Second 121 9¢3 224,045 111,084 -50 171,435 197,728 15
Third and Below 55 4¢2 74,887 35,995 -52 45,845 52,205 14
Fourth 9 0¢7 13,540 6,736 -50 7,918 8,125 3
Fifth 3 0¢2 3,578 2,160 -40 452 397 -12
Table 1: Characteristics of PhilHealth-accredited hospitals and year-on-year changes in medical admissions and procedures by hospital
characteristics, 2019-2020
*Three contiguous regions considered the epicenter of economic activity in the Philippines.
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private hospitals had smaller declines in the procedures
of cataract surgery, chemotherapy, C-section, and vagi-
nal delivery. The decline for these procedures in private
Level 3 hospitals was compensated by increases in utili-
zation in private Level 1 and Level 2 hospitals.
As additional information to strengthen our analysis,
we compared data from 2018 and 2019 year-on-year:
disease admissions increased by 5% and procedures by
7% (Supplementary Table 4). Looking at each disease
and procedure, there were increases in admissions for
Dengue (34%) and Pneumonia (14%) from 2018 to
2019 in contrast to their significant decline for 2019 to
2020 (Table 3). Otherwise, absolute utilization numbers
for 2019 were generally within +/- 9% of 2018 levels.
Discussion
COVID-19 has had a considerable and prolonged
impact on the utilization of non-COVID-19 inpatient
services in the Philippines. Comparing 2020 to 2019,
Figure 1.Monthly number of medical admissions and procedures in PhilHealth-accredited hospitals, 2019-2020
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we found a large decrease in disease admissions and a
small increase in procedure utilization. The overall
increase for procedures was due to a rise in hemodialy-
sis utilization surpassing its levels in 2019, overshadow-
ing the decline in for the two non-elective procedures of
C-section and vaginal delivery. Comparing the months
in 2020 to the same months in 2019, the precipitous
drop in inpatient admissions and procedures occurred
at the onset of the pandemic, during the strictest lock-
down period in March to April 2020. There was some
recovery in May 2020, but the trend was generally not
reversed for the rest of 2020. Non-urgent and respira-
tory diseases faced the largest declines, followed by dis-
eases requiring maintenance, then urgent and non-
elective with the least. Observed declines were generally
larger for (1) Level 3 hospitals, (2) the poorest patients,
and (3) hospitals in the south relative to the richer capi-
tal and north. Specifically for procedures, private hospi-
tals saw smaller declines, and even some growth,
compared to public hospitals.
Our results are broadly consistent with published evi-
dence in HICs and other LMICs that the pandemic
decreased utilization of essential non-COVID-19 health-
care: A multi-country systematic review reported a
median 37% (Interquartile range: -51% to -20%) reduc-
tion in healthcare utilization.3 The magnitude of drops in
healthcare utilization are comparable for non-urgent and
respiratory diseases in South Korea,20 dengue in China,21
diabetes in USA,18 acute coronary syndromes in Eng-
land,22 and stroke in 187 centers from 40 countries.23
In line with international literature,6,18 hospital
admissions decreased more steeply in vulnerable
groups. In our data, the declines in utilization were
three-times greater among indigent insurance members
compared to direct contributors and two-times more
among the southern islands compared to the richer
northern capital where COVID-19 was largely concen-
trated at the start of the pandemic. Various reasons, all
of which may affect the poor more than the rich, could
explain the large and sustained declines in hospital utili-
zation during the pandemic. First, patients may have
avoided going to hospitals out of fear as a national sur-
vey reported that 89% of the population were afraid of
being infected.24 Second, public transportation restric-
tions could have hindered access to hospitals. At the
start of the pandemic especially, strict border controls
and may have inhibited travel to hospitals in different
locales. Public transportation in mega-cities was shut
down from March to April 2020 under ECQ, and as of
writing, allowed operating capacities for public trans-
portation are still below pre-pandemic levels.25 Third,
rapid decline in income could have reduced household
purchasing power and demand for healthcare. The
country’s economy shrank by almost 10% in 2020 and
unemployment rates reached 17% and 10% in April and
July 2020.26
Limitations
Our study has several limitations. First, the pandemic
may have affected the timeliness and completeness of
hospital claims in 2020. However, the data was
extracted in April 2021, and four months would have
allowed hospitals to complete their claims filing. We
Strict Lockdown - “ECQ” (March-April) Easing of Lockdown - “M/GCQ” (May-Dec)
2019 % Change 2020 2019 % Change 2020
Total Claims 718,493 -11 2,912,914 -19
Claim Type
Medical Claims 285,648 -36 1,398,129 -61
Procedural Claims 432,845 -1 1,514,785 10
Hospital Location
National Capital Region, Region III, Region IVa 322,077 -8 1,243,449 -10
Luzon 122,091 -8 502,420 -14
Visayas 127,943 -17 540,551 -31
Mindanao 146,382 -16 626,494 -32
PhilHealth Membership Type
Direct Contributors 350,785 -7 1,389,567 -12
Formal 128,850 -11 580,566 -28
Informal 158,849 -6 597,081 -3
Lifetime Paid 63,086 -5 211,920 1
Indirect Contributors 367,708 -16 1,523,347 -26
Indigent or Poorest 177,299 -21 843,301 -39
Senior Citizen 190,409 -11 680,046 -10
Table 2: Year-on-year percent changes in medical admissions and procedures in PhilHealth-accredited hospitals across time periods by
hospital location and patient insurance membership type, 2019-2020
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further mitigated this by counting in-process claims.
Majority of the in-process claims were from October to
December 2020 (see Supplementary Table 3). The fact
our results observed a dramatic rise in claims for hemo-
dialysis in the last months of 2020 may be further evi-
dence that majority of the hospital claims for 2020 had
been filed.
Second, insurance claims do not necessarily reflect
actual need for healthcare. For example, declines in
admissions for respiratory and infectious diseases may
be due to true reductions in disease incidence caused
by non-pharmaceutical interventions (e.g., masks,
social distancing, handwashing) that decrease popula-
tion exposure to air pollution, pathogens, and vectors.
Even so, the decline in utilization for life-threatening
diseases (e.g., cancer, CKD) and diseases that require
follow-up (e.g., diabetes, hypertension), especially in
public hospitals, strengthens our argument that the
Figure 2. Same-month-prior-year percent changes in healthcare utilization by disease and procedure in PhilHealth-accredited hos-
pitals, 2019-2020
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pandemic negatively impacted non-COVID-19 inpa-
tient care.
Third, we do not include all diseases and procedures
reimbursed by PhilHealth. The 12 diseases and five pro-
cedures accounted for 49% and 32% of all paid medical
and procedural claims in 2019.27 Trends may be differ-
ent for other diseases or procedures, particularly non-
elective procedures, of which only one was captured in
this analysis.
Fourth, our analysis focused on disease admissions
and procedures done in hospitals. Currently, 7% of hos-
pitals are not PhilHealth-accredited, 13% of Filipinos
are not listed in the national SHI database, and 33% of
patients billed for inpatient care may not use Phil-
Health.28 While PhilHealth claims may capture acute
and severe events that require hospital care well, it does
not cover all healthcare utilization in the country for
these diseases and procedures. Changes in health-seek-
ing behavior may have shifted hospital care to home-
care, telemedicine, or primary care when possible.
PhilHealth does not reimburse the former two and has
limited outpatient- and primary-care packages. Never-
theless, in a country with weak population-based health
information systems, the PhilHealth database
represents the most comprehensive available dataset on
hospital utilization in the Philippines.
Added value
Our study contributes to the literature in three ways.
First, we provide estimates for disease admissions and
procedures that are not yet well-studied. Available litera-
ture for tuberculosis in LMICs have limited sample size
or focus on new case diagnosis and qualitative descrip-
tions of disruptions in primary care.29,30 Chemotherapy
utilization in the Philippines faced a modest drop of
30% in April 2020, but almost recovered to 2020 levels
by December 2020. Hemodialysis was peculiar:
monthly utilization in 2020 was similar for the same
months in 2019, with growth starting in August (13%)
to December 2020 (150%). In November 2020, Phil-
Health increased coverage of hemodialysis session from
90 to 144 sessions per year for 2020 as policymakers
were concerned about the affordability of this life-saving
health procedure during the pandemic.31
Second, we provide insight on equity by hospital
characteristics cross-tabulated with condition. Declines
were largest for Level 3 hospitals across diseases and
All Hospitals Public Hospitals Private Hospitals
2019 % Change 2020 All Level 1 Level 2 Level 3 All Level 1 Level 2 Level 3
Disease Admissions
Median -42 -43 -41 -43 -49 -43 -39 -42 -52
Interquartile Range 32 29 36 30 22 32 40 32 24
AGE 252,789 -55 -54 -51 -60 -63 -55 -49 -57 -65
Asthma 104,174 -66 -62 -62 -61 -67 -69 -69 -67 -71
COPD 42,250 -58 -14 -13 -15 -14 -19 -12 -17 -31
Dengue 364,392 -69 -57 -56 -55 -64 -59 -56 -60 -67
Pneumonia 730,346 -65 -20 -1 -12 -25 -8 16 1 -25
Diabetes 60,947 -31 -31 -24 -34 -45 -31 -20 -36 -47
Hypertension 208,759 -38 -74 -72 -76 -80 -64 -62 -65 -65
IHD 76,243 -35 -38 -34 -42 -50 -38 -28 -40 -56
Tuberculosis 40,171 -46 -39 -27 -39 -48 -32 -24 -34 -44
CKD 53,167 -17 -62 -62 -64 -63 -68 -70 -68 -63
Cancer 41,593 -14 -26 -5 -19 -40 -7 9 -7 -25
Stroke 127,679 -17 -46 -48 -43 -42 -47 -49 -44 -46
Procedures
Median -5 -17 -6 -21 -32 8 18 8 -23
Interquartile Range 21 13 51 27 31 −15 18 37 23
Cataract Surgery 93,516 -57 -71 -70 -32 -74 -54 -52 -47 -65
Chemotherapy 145,917 3 -11 -47 04 -11 12 18 34 -01
C-Section 331,532 -5 -17 4 -16 -32 8 24 8 -21
Hemodialysis 1,654,116 25 13 51 46 -5 27 26 33 16
Vaginal Delivery 160,779 -18 -24 -6 -26 -42 -3 6 -4 -25
Legend: Non-urgent and respiratory Diseases with maintenance Urgent and non-elective
Table 3: Year-on-year percent changes in disease admissions and procedures in PhilHealth-accredited hospitals by hospital ownership
and level, 2019-2020
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sectors. For procedures, private hospitals saw smaller
declines compared to public hospitals. Declines in non-
elective procedures in private Level 3 hospitals were
compensated by increases in lower-level private hospi-
tals— a trend absent in public hospitals.
Third and overall, we present an analysis that can
inform a whole-of-system strategy. While a growing body
of literature on the effect of COVID-19 on health care utili-
zation has been reported by HICs and other LMICs,3,5,32−34
they sought trends in one or a few diseases or disease areas
like maternal care. Meanwhile, there has been no LMIC in
Southeast Asia with similar research on a national scale
focusing on the country’s most burdensome diseases and
looking across lockdown stringency over time, levels of
care, and equity in patient access.
In part, our results may reflect the effect of pro-
longed lockdowns on hospital utilization in an LMIC.
The Philippines is unique in that varying degrees of
lockdown have been the mainstay response to COVID-
19 since March 2020. Contrary to most literature, which
identified a recovery period associated with better
national control over COVID-19,18,22,35 both admissions
and procedures in the Philippines generally had greater
cumulative decline during M/GCQ. Apart from lock-
downs, however, our results may also reflect intentional
and unintentional changes in health system conditions
caused by national policy and the progression of the
pandemic that must be considered more thoughtfully in
a holistic strategy to control COVID-19. Qualitative
reports suggest COVID-19 has overwhelmed public
health systems, with governments siphoning resources
to COVID-19 and reducing non-COVID-19 capacity.6,36
Though there were no hospital closures between 2019
and 2020 based for PhilHealth accredited facilities, hos-
pital capacity for non-COVID-19 services were reduced
by the designation of COVID-19 referral hospitals.37
Several large national and provincial secondary and ter-
tiary hospitals, of which there is usually only one in a
province, were designated as COVID-19 referral hospi-
tals.38 DOH also directed public and private hospitals to
allocate at least 30% and 20% of their total beds to
COVID-19.39 However, rising numbers of COVID-19
cases have pushed many facilities to critical capacity,
leading them to turn away both COVID- and non-
COVID patients.40−42
Similarly, limited health human resources were reallo-
cated to COVID-19 response, most evidently in public hos-
pitals unable to hire additional manpower. To exacerbate
the matter, many health workers resigned amidst worsen-
ing working conditions, including shortages of personal
protective equipment, increased work hours, and delayed
government assistance and release of hazard pay.43,44
Recommendations and implications
Global, national, and local government policymakers
must address the needs of both COVID-19 and non-
COVID-19 patients strategically. Instead of disease-spe-
cific approaches, a whole-of-health perspective consider-
ing all conditions and procedures, service delivery
networks, and access for the most vulnerable through
epidemic waves and lockdown restrictions is critical:
 Governments must prioritize conditions that require
hospitalization and direct patients to appropriate levels
of care, facilitating access not only for conditions with
immediate life-threatening consequences, but also
conditions that require maintenance to prevent future
long-termmorbidity andmortality.
 There must be a plan to follow-up with defaulters
during lighter lockdown periods. Lower-level hospi-
tals may be capacitated and maximized to facilitate
catch-up care.
 Focus and special protections can be given to lower-
level public hospitals and their health workers,
which may be the only hospitals accessible in poorer
provinces or rural areas.
 If public hospitals are overwhelmed, there is potential
for lower-level private hospitals to be tapped, given
they saw some growth in 2020 for procedures like C-
sections and chemotherapy despite the pandemic.
 As in the case of hemodialysis, SHI like PhilHealth
may play a role in improving the affordability of
healthcare during the pandemic, especially in acces-
sible private facilities.
 Mixed-methods and epidemiological research at the
community-level will be invaluable to uncovering
demand-side (e.g., fear of infection) and supply-side
reasons (e.g., public hospitals becoming COVID-19
referral centers) for healthcare utilization trends, the
development of public communication strategies, and
uncovering further effects of lockdowns on hospital
finances and population health outcomes.
As of August 2021, less than 10% of the Philippine
population has been fully vaccinated against COVID-
19.45 The presence of the delta variant and a surge of
cases has precipitated a return to ECQ in the capital
region and further strain to overburdened hospitals and
health care workers.46 Considering our results and the
current context, we believe these deleterious effects on
hospital utilization continue today.
Our results suggest a looming public health crisis in
the long-term for the Philippines and other LMICs with
frail health systems. Foregone care for infectious dis-
eases such as AGE and pneumonia may exacerbate the
already high prevalence of chronic childhood malnutri-
tion (30% among under-5 children) in the country.47
Eight of the top 12 PhilHealth inpatient claims pertain
to noncommunicable diseases (NCDs). In a country
where 68% of deaths are due to NCDs,48 forgone
urgent and non-urgent hospital care for NCDs may lead
to an increase in premature mortality, debilitating and
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impoverishing complications, and a surge in future
demand for rehabilitation services.49
As LMICs struggle to navigate the multi-dimen-
sional complexities of direct and indirect effects of the
COVID-19 pandemic, global partners have a key role in
capacitating governments to think strategically and
operationalize holistic recommendations such as those
listed above.8 Likewise, national leaders have the same
role of capacitating hospitals and local government lead-
ers at the subnational level. Governments and health
systems, most crucially in countries that frequently use
lockdowns as a significant means of COVID-19 control,
must ensure patients with conditions requiring hospi-
talization can access it with ease and financial protection
during this protracted pandemic.
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